Johann K Hitzler

32PUBLICATIONS
152CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 29, 2026
How I Approach Treatment of Relapsed Acute Lymphoblastic Leukemia in Patients With Down Syndrome.

|Apr 20, 2026
IFNγ Drives Long-Term Bone Marrow Niche Dysfunction Following Doxorubicin-Based Chemotherapy.

|Apr 07, 2026
DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia.

Lonneke Verboon, Sonali P Barwe, Meredith Tavenner

|Mar 18, 2026
T-Cell Lymphoblastic Lymphoma in a Child With Trisomy 21: A Unique Case Demonstrates the Need for Malleability in Therapy.

Sydney Tape, Stuart Winter, Lane Miller

|Oct 22, 2025
Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease.

Jason N Berman, Anupam Verma, Shelton Viola

|Oct 17, 2025
DNA methylation alterations in acute lymphoblastic leukemia survivors with late neurocognitive deficits.

Sarah J Goodman, Darci T Butcher, Sharon L Guger

Pageof 6

Frequent Collaborators

5 joint publications

Reuven Schore

4 joint publications

Sarah Cohen-Gogo

3 joint publications

Adam Shlien

3 joint publications

Mohamed Abdelhaleem